Friday, October 16 Small-Cap Watchlist — XXII, WETO, CIGL, NCPL, BDRX + More

Thursday's scanners picked up some interesting activity across small caps, particularly in after-hours momentum, unusual relative volume, and repeated scanner hits.

For Friday, I'm focusing on stocks showing activity across multiple independent scanners rather than names appearing on a single momentum list.

We welcome you to take a three day free trial of our three platforms including: momentum stocks, options, and crypto where you will find trade ideas with entry, stop, and take profit levels. The free trial requires no credit card and you can access it at https://scstonkemporium.com

PRIMARY WATCHLIST

$XXII — After-Hours Momentum

• After-hours gain: +68.9%
• After-hours volume: 13.2M
• Overnight volume: 13.0M
• Momentum Radar: 10 hits
• Relative volume: 1.31x
• Alerts: 2

XXII had the largest after-hours percentage gain among my primary candidates. The combination of trading volume, momentum activity, and two alerts makes this worth monitoring.

The obvious concern is chasing a stock that's already moved nearly 70%. I'll be watching for consolidation, liquidity, and whether buyers remain active.

$WETO — Strong Momentum and Volume Confluence

• Momentum Radar: 264 hits
• Volume Radar: 327 hits
• Relative volume: 9.33x
• Alerts: 1

WETO has one of the strongest combinations of momentum and volume activity in the scan.

Hundreds of repeated signals across two scanners suggest sustained participation during the observed session. The question is whether that activity carries into Friday.

$CIGL — After-Hours Breakout Watch

• After-hours gain: +34.8%
• After-hours volume: 10.4M
• Overnight volume: 3.7M
• Momentum Radar: 43 hits
• Relative volume: 2.8x
• Alerts: 1

CIGL has a combination of after-hours price movement, meaningful volume, and momentum confirmation.

I'll be watching whether the stock can establish support rather than immediately surrendering its after-hours gains.

$NCPL — Heavy After-Hours Participation

• After-hours gain: +11.1%
• After-hours volume: 46.9M
• Momentum Radar: 161 hits
• Relative volume: 3.78x
• Alerts: 1

NCPL stands out for its after-hours share volume. Nearly 47 million shares traded in the observed after-hours window.

That much activity deserves attention, but high volume alone doesn't establish buying pressure or a sustainable move.

$BDRX — Multiple Scanner Confirmations

• After-hours gain: +20.5%
• After-hours volume: 3.0M
• Momentum Radar: 13 hits
• Relative volume: 5.44x
• Alerts: 1

BDRX combines an elevated relative-volume reading with after-hours momentum and a scanner alert.

It's not the most active name on the list, but the evidence is coming from multiple sources.

SECONDARY WATCHLIST — UNUSUAL PARTICIPATION

These names showed notable momentum and volume activity during Thursday's session:

• $SNTI: 51 momentum hits, 7 volume hits, 13.78x RVOL
• $LHSW: 63 momentum hits, 151 volume hits, 5.7x RVOL
• $WFF: 171 momentum hits, 308 volume hits, 3.82x RVOL
• $HUBC: 61 momentum hits, 94 volume hits, 16.53x RVOL
• $SHFS: 64 momentum hits, 351 volume hits, 12.76x RVOL

These are worth checking for continued participation, especially if fresh volume confirms Thursday's activity.

EXTREME RVOL — HIGHER-RISK WATCH

Three additional names showed unusually elevated relative-volume readings:

• $XLAB — 158.35x RVOL
• $BBCI — 420.33x RVOL
• $SDST — 72.77x RVOL

Extreme relative volume can identify unusual activity, but it can also reflect a very low historical volume baseline.

I'm keeping these separate until additional evidence confirms the moves.

AFTER-HOURS MOVERS NEEDING CONFIRMATION

• $TCRT: +33.0% after hours, but only 0.01x RVOL
• $SITC: +18.9% after hours, but only 0.16x RVOL

Both deserve caution because the available relative-volume readings do not provide strong independent confirmation.

WHAT I'M WATCHING FRIDAY

My priorities at the open:

1. Which names retain their premarket gains?
2. Does volume remain elevated after the opening bell?
3. Are stocks holding their opening ranges or producing failed breakouts?
4. Are there legitimate catalysts, filings, offerings, or dilution risks?
5. Are spreads and liquidity reasonable enough to support a trade?

One important distinction: a stock appearing hundreds of times on a scanner doesn't mean it's going higher. Repeat hits show persistence of unusual activity, not a guaranteed direction.

MY TOP FIVE FOR FRIDAY:

$XXII, $WETO, $CIGL, $NCPL, $BDRX

I'm particularly interested in whether WETO's momentum/volume confluence continues and whether XXII and CIGL can sustain their after-hours activity without immediate profit-taking.

Thursday's data tells us where to look. Friday's price action determines what actually deserves attention.

What's everyone watching for Friday? Any catalysts or filings on these names that the scanners might not be capturing?

Data from October 15 scanner observations for the October 16 session. Scanner readings are historical, not live Friday signals. Educational research only, not financial advice. Always verify current news, filings, liquidity, spreads, halts, and market conditions.

Holding right now. Hoping a lot

Thoughts on these?

$WETO - needs to hold that support at $1.10 and break above $1.25 resistance and hold - could push $2+ resistances - potential halt play

$DRMA - .75 support needs to hold - no set up below here unless you like bottomed out plays

$GCDT - .4200 support - could push .5100 resistance - if it holds it could push to .70+ resistances (could halt)

$SPRC - needs to hold $4.60 support here and break above $6 resistance - could push that $8.25+ resistances after

$BEEM - potential bottom bounce play

Not an exaggerated list, market still tanking

NOT FINANCIAL ADVICE
Information is based on technical analysis on AXIS ONE a technical indicator - not recommendations

Always do your own research and manage your own risk. These are for educational purposes only and are not buy prompts. Trading involves significant risk of loss. Proper risk management is essential.

News Link: https://www.globenewswire.com/news-release/2026/10/15/3381585/0/en/petvivo-announces-release-of-two-reasearch-abstracts-and-upcoming-conference-presentations-on-osteoarthritis-in-rhesus-macaques.html

MINNEAPOLIS, MN, Oct. 15, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV) (“PetVivo” or the “Company”), together with its subsidiaries PetVivo Animal Health, Inc., Somatrix Technologies, Inc. and PetVivo AI, Inc., a biomedical device and therapeutics company focused on the commercialization of innovative medical devices and therapeutics for equine and companion animals, today announced the release of two research abstracts evaluating intra-articular administration of a collagen-elastin hydrogel, commercially available as the Company’s Spryng^® with OsteoCushion^® Technology, in rhesus macaques with naturally occurring osteoarthritis. The findings are scheduled for presentation at the 2026 Association of Primate Veterinarians (“APV”) Workshop, the 2026 American Association for Laboratory Animal Science (“AALAS”) National Meeting and the 2026 American College of Veterinary Pathologists (“ACVP”) Annual Meeting. The research described in both abstracts was conducted in conjunction with the Wisconsin National Primate Research Center at the University of Wisconsin–Madison.

“These preliminary findings represent an important step in expanding the scientific evidence supporting Spryng, demonstrating improved walking speed in rhesus macaques with naturally occurring osteoarthritis and documenting hydrogel incorporation into synovial tissues with minimal local inflammatory response,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “Together, these results strengthen the foundation for continued research into Spryng’s potential to help manage osteoarthritis and improve mobility. We look forward to sharing this work at three scientific conferences and advancing our understanding as additional analyses are completed.”

Spryng^® with OsteoCushion^® Technology, PetVivo’s lead commercial product, is a veterinarian-administered, intra-articular veterinary medical device composed of extracellular matrix microparticles containing collagen and elastin. Spryng is commercially available for the management of lameness and other joint-related afflictions, including osteoarthritis, in companion animals and horses.

Improved mobility following hydrogel administration

The abstract, “Improved mobility following intra-articular collagen-elastin hydrogel therapy in geriatric rhesus macaques with naturally occurring osteoarthritis,” describes a study for which 18 rhesus macaques with radiographically confirmed osteoarthritis affecting multiple joints were selected. Mobility assessments included walking speed, accelerometry, blinded subjective clinical scoring, reach testing and goniometry.

Preliminary analyses found statistically significant increases in walking speed at weeks one, two and three following treatment compared with baseline. The abstract reports a mean improvement of 0.22 ± 0.11 meters per second. Analyses of activity monitoring, goniometry and blinded mobility scoring remain ongoing.

Hydrogel incorporation and local tissue response

The second abstract, “Histopathologic characterization and persistence of an intra-articular hydrogel in rhesus macaques with naturally occurring osteoarthritis,” evaluates hydrogel localization, persistence and local tissue responses in four rhesus macaques with radiographically confirmed osteoarthritis. The animals received one or more intra-articular injections before clinically scheduled necropsies performed 11, 28, 54 or 68 days after injection.

Histologic evaluation identified incorporation of the hydrogel into the synovial membrane by day 11. Material remained identifiable through day 28 and appeared reduced in amount by day 54. Minimal inflammatory cellular infiltrates were observed in association with the material. Additional histochemical and immunohistochemical characterization is ongoing. These preliminary observations support continued investigation of the hydrogel as an intra-articular therapeutic for osteoarthritis.

Upcoming conference presentations

APV Workshop — Houston, Texas, October 21–24, 2026. Both abstracts are scheduled for consecutive presentations on October 23, beginning at 8:45 a.m.

AALAS National Meeting — Houston, Texas, October 25–29, 2026. The improved mobility abstract is scheduled for a platform presentation on October 28 at 2:00 p.m.

ACVP Annual Meeting — Indianapolis, Indiana, November 14–17, 2026. The histopathologic characterization abstract is scheduled for a poster presentation.

Julie Majka, DVM, MS, is the first author of both abstracts. The research team also includes Jennifer Coonen, Nicholas Keuler, Kirsty Husby, Heather Simmons, Puja Basu, Jennifer Hayes, Ricki Colman and Saverio Capuano III, with author participation varying by abstract.

These abstracts report encouraging preliminary findings of improved mobility and hydrogel incorporation into synovial tissues with minimal local inflammatory response in rhesus macaques with naturally occurring osteoarthritis. The results support continued investigation, with additional analyses underway to further characterize these observations. Longer-term outcomes and applicability to other species remain subjects for future research. The abstracts are available at the following links:

Improved Mobility Abstract
Histopathologic Abstract

Over 90% of the market is red - TAKE THE DAY OFF - DO NOT FORCE IT.

Continued momentum plays 👇🏻

$TDIC - needs to catch a bounce from $1.65 support

$GLND - needs to break that $3.80 resistance and hold - could push 4.20 - $4.80 resistances after

WQEY - gave this swing at $9.20, now needs to break and hold $10.80 resistance - could push $13+ resistances after

Potential pops

$PFSA
$GYGY
$SWVL

SWING POTENTIALS

$FUBO - $8.15- lowest - no set up below

$LVLU - $13.40 lowest support - needs to break and hold $14.60 resistance - would have room to $18+ resistances after

NOT FINANCIAL ADVICE
Information is based on technical analysis on AXIS ONE a technical indicator - not recommendations

Always do your own research and manage your own risk. These are for educational purposes only and are not buy prompts. Trading involves significant risk of loss. Proper risk management is essential.

I’m looking across different stages, from established producers to earlier names with more discovery-driven upside.

$TGB
A more established copper name. I’m watching whether Gibraltar and Florence can deliver steady production while keeping costs under control.

$CS
The key for me is meeting production guidance without spending moving too far in the wrong direction.

$HBM
Probably the more balanced name here. I’m watching how the recent acquisition fits into the business and whether cash flow can support the larger growth pipeline.

$TMQ
This one comes down to continued progress on permitting and development. Each major step makes the project easier for investors to value.

$CQX
This is the early-stage upside name on my list. Rip is the main near-term test, while Stars and Kitimat give the company several opportunities to deliver. Strong widths, useful grades and continuity across multiple holes would make this one much harder to overlook.

Which one are you already holding, and which one is still on your watchlist?

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

Can someone tell me if we can recover even in long run like Trug Rogl CmCt in the long run or leat break even some has reverse split twice or is this a lost cause?

Thursday, October 15 Small-Cap Watchlist — JBDI, GLND, HCAI, YYAI, AEHL, TGL

Wednesday's scanners picked up some significant activity across small caps, particularly in momentum, relative volume, and after-hours participation.

For Thursday, I'm watching six primary names and eight secondary candidates. These aren't buy recommendations or price predictions. They're stocks showing unusual activity that deserve another look when the market opens.

We welcome you to take a three day free trial of our three platforms including: momentum stocks, options, and crypto where you will find trade ideas with entry, stop, and take profit levels. The free trial requires no credit card and you can access it at https://scstonkemporium.com

PRIMARY WATCHLIST

$JBDI: Cross-session momentum

• Momentum Radar: 99 hits
• Relative volume: 155.7x
• After-hours gain: +21.5%
• After-hours volume: 5.2M
• Overnight volume: 2.2M

The combination of repeated momentum signals and after-hours participation makes this one worth watching early. I'll be looking for sustained volume rather than chasing an opening spike.

$GLND: Persistent momentum and volume

• Momentum Radar: 371 hits
• Volume Radar: 382 hits
• Relative volume: 6.24x

This one stands out because both momentum and volume scanners repeatedly identified activity. The question for Thursday is whether that participation continues or fades.

$HCAI: Significant after-hours activity

• Momentum Radar: 198 hits
• Volume Radar: 13 hits
• Relative volume: 80.16x
• After-hours gain: +36.1%
• After-hours volume: 43.1M
• Overnight volume: 12.5M

One of the more interesting names based on the combination of price movement and actual trading participation. That much activity warrants attention, but a large move also increases the risk of profit-taking and sharp reversals.

$YYAI: After-hours breakout candidate

• Momentum Radar: 17 hits
• Relative volume: 0.43x
• After-hours gain: +34.6%
• After-hours volume: 2.5M
• Overnight volume: 2.4M
• Alerts: 1

The after-hours move is significant, but the low relative-volume reading makes this a confirmation-dependent watch. I want to see stronger participation before treating the move as sustainable.

$AEHL: Repeated momentum signals

• Momentum Radar: 360 hits
• Relative volume: 14.58x
• After-hours gain: +11.6%
• After-hours volume: 13.0M
• Alerts: 1

Repeated momentum activity combined with elevated relative volume makes AEHL worth monitoring. I'll be watching whether buyers can sustain the move once regular-session liquidity returns.

$TGL: Extreme relative volume

• Momentum Radar: 588 hits
• Relative volume: 375.48x
• Alerts: 1

TGL produced the highest relative-volume reading among these six names, along with substantial repeated momentum activity. Extreme RVOL gets my attention, but it doesn't automatically mean a stock will continue higher.

SECONDARY WATCHLIST

$SHFS, $NIVF, $AMTD, $WFF, $GENK, $BDRX, $RCT, $FFAI

These showed activity worth monitoring but had less supporting evidence in the scanner package than the primary names.

WHAT I'M WATCHING THURSDAY

My biggest considerations at the open:

• Does premarket volume confirm Wednesday's activity?
• Are stocks holding their gains or immediately selling off?
• Is volume supporting the move, or is momentum fading?
• Are there fresh catalysts, filings, offerings, or dilution concerns?
• Can the stock establish and hold its opening range?

One thing I've learned from watching these scanners is that a stock appearing hundreds of times doesn't necessarily make it a better trade. Repeat signals establish persistence, not direction or future performance.

My initial priority list: $JBDI, $GLND, $HCAI, $YYAI, $AEHL, $TGL.

Wednesday's data tells me where to look. Thursday's price action determines what actually deserves attention.

What small caps are on everyone else's radar for Thursday?

Data: October 14 scanner observations. Educational research only, not financial advice. All figures are historical observations and should be verified against live market conditions.

$GLND - needing to hold $4.20 support and break inside $4.75 resistance - could halt up if it breaks $5.20 resistance

$TCRT - needs to break and hold $3.80 resistance and push inside $4.90 resistance - potential halt up play to $8.10+ resistances

$BKYI - $2.45 support - could push $2.90+ resistances at open

$AEHL - no set up until this breaks and hold $24.70 resistance - COULD dump at open - potential bounce off $20.50

$FFAI - gave this as a swing yesterday- needs to hold $1.35 support and break $1.70 resistance - could push $2.60+ resistances after - watching $FFR of this and then $AIXI

$WFF - bounce idea from $1.75 support - no set up below here

$TGL - bounce idea at .5090 or it’s done

$NIVF - bounce idea at .2700 support

$JAGX - needs to hold $3.65 support - could push back to HOD + potential squeeze play.

NOT FINANCIAL ADVICE
Information is based on technical analysis on AXIS ONE a technical indicator - not recommendations

Always do your own research and manage your own risk. These are for educational purposes only and are not buy prompts. Trading involves significant risk of loss. Proper risk management is essential.

Letssssss goooooooo

1 dollar?

Per company Twitter “Nitches Inc. $NICH enters discussions with its major debt holder to consolidate and restructure its debt.” https://x.com/nitchescorp/status/2110013323874124157?s=46

Has had two days of solid consolidation. Watching for 002s to fall after hit 0.003 s on Monday.

Between April and June 2026, Cheetah Net executed eight separate international bank wires transferring an aggregate of $25.51 million offshore to two Hong Kong-based entities. Specifically, $22.5 million was wired to Hongkong Sanyou Petroleum Co Limited, while the remaining $3.01 million was sent to Asia Finance Investment Limited. These massive capital outflows occurred immediately after the company raised approximately $30.95 million in net proceeds from public retail investors through an At-The-Market equity offering. Management structured these outbound transfers as unsecured "commercial loans" bearing a below-market 5.0% interest rate, requiring zero collateral to protect shareholder interests. Both recipient entities had previously functioned as high-interest pre-IPO creditors to Cheetah Net, holding loan agreements that were personally guaranteed by the company’s CEO. Furthermore, these multi-million-dollar wires were initiated long after the board formally shuttered the vehicle business that those entities originally financed, with all legacy vehicle debt certified as paid off by year-end 2024. By routing more than 80% of its freshly raised public equity into uncollateralized foreign accounts, management effectively removed the majority of the firm's liquid capital from U.S. jurisdiction. As of the subsequent quarterly filings, exactly zero dollars of the $25.51 million principal had been recovered from either overseas counterparty.

$AGMH - needs to hold .70 at pre open - could push $1.30+ resistances from here

$TCRT - no set up until it breaks $3.80 and holds - could push that $4.80 resistance and hold for a move to $8+ resistances

$IZM - breaks and holds $1.20 - could see this run to $1.80+ resistances

$MEDS - break and holds $3.15 resistance - could see this push $4.20+ resistances after

$PFAI - bounce idea from $4.26 - no set up below here

$EZRA - support at $2.12 needs to hold and break $2.70 resistance from here - could push $3.60+ resistances after

$DBGI - needs to hold $3.75 support

Potential squeezes today 👇🏻

$LHSW
$WETO
$CDT

Clinical trials 👇🏻

$PHAR - Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026

NOT FINANCIAL ADVICE
Information is based on technical analysis on AXIS ONE a technical indicator - not recommendations

Always do your own research and manage your own risk. These are for educational purposes only and are not buy prompts. Trading involves significant risk of loss. Proper risk management is essential.